Daclatasvir and sofosbuvir treatment of decompensated liver disease or post‐liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a rea...

por Kwo, Paul, Fried, Michael W., Reddy, K. Rajender, Soldevila‐Pico, Consuelo, Khemichian, Saro, Darling, Jama, Zamor, Phillippe J., Napoli, Andrew A., Anduze‐Faris, Beatrice, Brown, Robert S.
Publicado 2018

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis

por Radhakrishnan, Kavita, Di Bisceglie, Adrian M., Reddy, K. Rajender, Lim, Joseph K., Levitsky, Josh, Hassan, Mohamed A., Darling, Jama M., Feld, Jordan J., Akushevich, Lucy, Vainorius, Monika, Nelson, David R., Fried, Michael W., Brown, Robert S., Terrault, Norah A.
Publicado 2019

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

por Welzel, Tania M, Nelson, David R, Morelli, Giuseppe, Di Bisceglie, Adrian, Reddy, Rajender K, Kuo, Alexander, Lim, Joseph K, Darling, Jama, Pockros, Paul, Galati, Joseph S, Frazier, Lynn M, Alqahtani, Saleh, Sulkowski, Mark S, Vainorius, Monika, Akushevich, Lucy, Fried, Michael W, Zeuzem, Stefan
Publicado 2017

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study

por Sulkowski, Mark S., Moon, Juhi S., Sherman, Kenneth E., Morelli, Giuseppe, Darling, Jama M., Muir, Andrew J., Khalili, Mandana, Fishbein, Dawn A., Hinestrosa, Federico, Shiffman, Mitchell L., Di Bisceglie, Adrian, Reddy, K. Rajender, Pearlman, Brian, Lok, Anna S., Fried, Michael W., Stewart, Paul W., Peter, Joy, Wadsworth, Summer, Kixmiller, Scott, Sloan, Anquenette, Vainorius, Monika, Horne, Patrick M., Michael, Larry, Dong, Meichen, Evon, Donna M., Segal, Jodi B., Nelson, David R.
Publicado 2021